Before joining Kelly, Mark successfully directed departments within Abbott International, i3-Statprobe, Pfizer Research and Development, KV Pharmaceuticals, and Roche/Genentech. He was vice president of Worldwide Strategic Alliances for Kforce Clinical Research and vice president of Clinical Operations and Development for Advanced Clinical, a full-service CRO in Chicago. For almost two decades, Mark has operated clinical trials in the U.S., Western and Eastern Europe, Mexico, India, and South America. In addition, he has directed drug and device approvals though the Eastern European Ministries of Health. Mark is a graduate of the University of Michigan, holding degrees in health care sciences and biological sciences.
'Missing' talent can cause workplaces to miss strategic targets. In this short clip, I talk about new kinds of collaboration in the pharmaceutical industry and how cost savings are being achieved with new workforce strategies to fill talent gaps. Watch the clip now.
Privacy Statement | Accessibility Statement | Code of Conduct | Site Map Copyright